Longeveron Inc.
Longeveron Inc. is listed today as Longeveron Inc.: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2026 | $16 M | Private placement after listing | $10 to $50 million | equity, options | SEC | |
| Dec 2021 | $20 M | No. 1 | $10 to $50 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Longeveron Inc., its revenue in fiscal 2025 came from these product and service lines: Clinical trial revenue $950,000 (80%), Contract manufacturing revenue $220,000 (19%), Contract manufacturing lease revenue $20,000 (2%).
Annual report (SEC XBRL) · Dec 2025
Longeveron Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2026).
SEC Form D · Mar 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Mar 2026
Products and services#
No products or services of Longeveron Inc. are on record.
Investors#
No investor of Longeveron Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 20 investors.
Largest shareholders today
Institutions holding Longeveron Inc. shares, as of Sep 30, 2026.
- Logos Global Management LP$1 M—
- Janus Henderson Group Ltd.$0 M—
- Vanguard Capital Management LLC$0 M—
- Geode Capital Management, LLC$0 M—
- BlackRock, Inc.$0 M—
- HRT Financial LP$0 M—
- Vanguard Fiduciary Trust Co$0 M—
- ADAR1 Capital Management, LLC$0 M—
- Beacon Pointe Advisors, LLC$0 M—
- Tower Research Capital LLC (TRC)$0 M—
- Jones Financial Companies Lllp$0 M—
- Steward Partners Investment Advisory, LLC$0 M—
- SBI Securities Co., Ltd.$0 M—
- Osaic Holdings, Inc.$0 M—
- Allworth Financial LP$0 M—
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Devin A. Blass | Executive officer | Mar 2026 |
| Joshua M. Hare | Executive officer | Mar 2026 |
| Lisa A. Locklear | Executive officer | Mar 2026 |
| Nataliya A. Agafonova | Executive officer | Mar 2026 |
| Paul A. Lehr | Executive officer | Mar 2026 |
| Stephen H. Willard | Executive officer | Mar 2026 |
| Geoff Green | Executive officer | Dec 2021 |
| James Clavijo | Executive officer | Dec 2021 |
| Joshua Hare | Executive officer | Dec 2021 |
| Paul Lehr | Executive officer | Dec 2021 |
| George Joseph Paletta, Jr. | Director | Mar 2026 |
| Joshua M. Hare | Director | Mar 2026 |
| Rock A. Soffer | Director | Mar 2026 |
| Roger Joseph Hajjar | Director | Mar 2026 |
| Ursula A. Ungaro | Director | Mar 2026 |
| Cathy Ross | Director | Dec 2021 |
| Donald Soffer | Director | Dec 2021 |
| Douglas Losordo | Director | Dec 2021 |
| Erin Borger | Director | Dec 2021 |
| Joshua Hare | Director | Dec 2021 |
| Neil Hare | Director | Dec 2021 |
| Rock Soffer | Director | Dec 2021 |
| Ursula Ungaro | Director | Dec 2021 |
Went public since 2021. Its SEC number is that of a company listed on a stock exchange.